Home

Kathleen Tregoning

CIK 1830764 · See Remarks · last filed 2026-07-08

Kathleen Tregoning is a corporate insider who has filed 19 SEC Form 4 insider transactions across 5 companies since 2020. The most recent filing, for KLRA, was dated Jul 8, 2026. Across all open-market trades the lifetime net is −$260.5K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $101.6K across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$101.6K

Companies

5

Total Filings

19

Lifetime Open-Market Net

-$260.5K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
KLRA See Remarks — $16.74 — $0 1 2026-07-08
SPRO Director 85,000 $1.20 $101.6K $0 9 2026-06-25
CMPS Director — $10.85 — $0 1 2026-05-29
Cerevel Therapeutics Holdings, Inc. (CERE) Delisted See Remarks 10,666 $44.96 $479.5K -$260.5K 5 2024-01-23
Cerevel Therapeutics Holdings, Inc. (CEREW) Delisted See Remarks — $18.07 — $0 2 2021-02-05

Recent Filings

19 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-07-08 KLRA Grant (A) — $0 EDGAR
2026-06-25 SPRO Grant (A) +10,000 $0 EDGAR
2026-05-29 CMPS Grant (A) — $0 EDGAR
2025-06-16 SPRO Grant (A) +20,000 $0 EDGAR
2024-08-05 — Disp (D) −10,666 $0
2024-05-30 SPRO Grant (A) +20,000 $0 EDGAR
2024-01-23 Cerevel Therapeutics Holdings, Inc. (CERE) Delisted Grant (A) — $0 EDGAR
2024-01-04 SPRO Grant (A) — $0 EDGAR
2023-12-28 Cerevel Therapeutics Holdings, Inc. (CERE) Delisted Exer (M) +3,150 $31.7K EDGAR
2023-12-21 Cerevel Therapeutics Holdings, Inc. (CERE) Delisted Mixed +7,516 -$260.5K EDGAR
Showing 1–10 of 19
Page 1 of 2
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.